Related Experiment Video
Updated: May 25, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Castration-resistant prostate cancer: surgical and radio-oncological therapeutic options]
S Preusser1, P M Putora, L Plasswilm
1Klinik für Urologie, Kantonsspital St. Gallen, Rorschacher Straße 95, CH-9007 St. Gallen, Schweiz. stefan.preusser@kssg.ch
Abstract:
Treatment of patients suffering from castration-resistant prostate cancer is a challenge for the attending physician. Due to the polysymptomatic nature of this disease, multidisciplinary cooperation (urology, radiation oncology, medical oncology, palliative care, orthopaedics, neurosurgery) is the centre of attention. Different surgical and radio-oncological therapeutic options are available based on different stages of this disease. Optimizing quality of life should always be the focus of attention in these patients.
Related Concept Videos
Treatment Resistent Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Urinary Tract Calculi VI: Surgical Management

